This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2025 summit.

Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS for ASO – New Data

Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS for ASO – New Data

By | 5 February 2026

Presenting a novel drug delivery system for antisense oligonucleotides
Achieving success in non-clinical experiments
Showcasing early clinical results